Evaluation of disease-free survival (DFS) as a surrogate for overall survival (OS) in the adjuvant therapy of HER2-positive early breast cancer (EBC) calls for individual-patient data (IPD)

著录项

• 来源
  《The Breast :》 |2017年第2017期|共1页
• 作者

  Saad E.; Delaloge S.; Mavroudis D.; Perez E.; Piccart-Gebhart M.; Schneider B.; Wolmark N.; Buyse M.; Burzykowski T.;

  展开▼
• 作者单位

  Int Inst Drug Dev Louvain La Neuve Belgium;

  Inst Gustave Roussy Paris France;

  Univ Crete Iraklion Greece;

  Genentech Inc San Francisco CA USA;

  Inst Jules Bordet Brussels Belgium;

  Indiana Univ Med Ctr Indianapolis IN USA;

  Natl Surg Adjuvant Breast &

  Bowel Project Pittsburgh PA USA;

  Int Inst Drug Dev San Francisco CA USA;

  Int Inst Drug Dev Louvain La Neuve Belgium;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 胸部外科学;
• 关键词